ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Editas Medicine is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.4 as stoploss in an intra day buy trade for a target of 2.5. However, stock will show a bearish move below 2.4.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Credit provided by capital markets will overtake bank credit: Kotak Mahindra AMC chief Nilesh Shah Mutual fund credit is set to surpass bank credit. Nilesh Shah of Kotak Mahindra AMC predicts this shift. He urges Indians to invest wisely, moving away from unproductive habits. Radhika Gupta of Edelweiss Mutual Fund suggests incentives for early investmen - NEWS as on 2025-12-09 indiatimes.com

Banks and NBFCs remain healthy, credit to commercial sector rises, says RBI Governor The Reserve Bank of India reported robust financial parameters for banks and non-banking finance companies, facilitating increased resource flow to the commercial sector. Capital adequacy and asset quality remain strong, with credit growth bolstered by gre - NEWS as on 2025-12-05 indiatimes.com

RBI orders weekly loan data reporting to credit information cos from April 1, 2026 RBI has mandated that lenders submit borrower data to credit bureaus weekly instead of fortnightly from April 1, 2026. The move aims to improve credit underwriting and loan monitoring. Lenders must update data on fixed dates each month, share full monthly - NEWS as on 2025-12-04 indiatimes.com

Credit Acceptance Reaches Analyst Target Price In recent trading, shares of Credit Acceptance Corp (Symbol: CACC) have crossed above the average analyst 12-month target price of 4.40, changing hands for 6.24/share. When a stock reaches the target an analyst has set, the analyst logically has tw - NEWS as on 2025-12-03 nasdaq.com

MFI body seeks greater penetration of credit flow for growth Microfinance institutions in West Bengal need more credit to reach the bottom of the pyramid. Currently, only one-third of the target segment accesses formal credit. This gap hinders economic activity and sector growth. India's MFI sector has Rs 3.4 lakh c - NEWS as on 2025-12-02 indiatimes.com

Private Credit will be crucial in achieving India’s trillion real estate ambition: Siddharth Chowdhary India's real estate sector is set for a major shift. Private credit is becoming a key driver for the nation's one trillion dollar real estate goal. Institutional investors are increasing their real estate allocations. This trend offers stability and divers - NEWS as on 2025-11-28 indiatimes.com

Subdued H2 credit offtake ahead for banks, NBFCs: CareEdge Any incremental growth is likely going to be driven by a pickup in retail lending segments such as housing, MSME, two-wheelers, and gold loans. But analysts expect the asset quality to remain stable, despite growing retail demand. The agency has upgraded i - NEWS as on 2025-11-28 indiatimes.com

Is American Express the Credit Stock For a K-Shaped Economy? Consumer delinquency rates are on the rise, and recent market volatility shows investors are on edge as economic worries drag sentiment down. Shares of Visa Inc. (NYSE: V) and Mastercard Inc. (NYSE: MA) have barely moved since April despite quality ea - NEWS as on 2025-11-27 nasdaq.com

SBI gears up for massive credit push: Chairman says no new equity needed for 6 years as bank plans Rs 12,500 cr bond raise in FY26 State Bank of India Chairman C S Setty is confident in the bank's strong capital position. He stated that recent equity capital raised will support substantial credit growth for the next five to six years. The bank also plans to continue bond issuances as - NEWS as on 2025-11-27 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.42
  • 12Day Average: 2.38
  • 20Day Average: 2.46
  • 50Day Average: 3.07
  • 100Day Average: 2.93
  • 150Day Average: 2.64
  • 200Day Average: 2.33

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.41, 2.59, -0.2
Indicator MACD is in negative zone

Indicator ADX (14)

0, 35, 35
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Dec 2025 2.44 2.36 to 2.49 0.83% 0.89 times
08 Mon Dec 2025 2.42 2.37 to 2.51 0% 0.81 times
05 Fri Dec 2025 2.42 2.38 to 2.50 -0.82% 1.01 times
04 Thu Dec 2025 2.44 2.29 to 2.49 2.95% 1.02 times
03 Wed Dec 2025 2.37 2.12 to 2.37 12.32% 1.46 times
02 Tue Dec 2025 2.11 2.09 to 2.31 -3.65% 1.21 times
01 Mon Dec 2025 2.19 2.16 to 2.38 -9.13% 1.25 times
28 Fri Nov 2025 2.41 2.34 to 2.41 0.42% 0.76 times
26 Wed Nov 2025 2.40 2.33 to 2.41 0.42% 0.79 times
25 Tue Nov 2025 2.39 2.35 to 2.52 -4.02% 0.91 times
24 Mon Nov 2025 2.49 2.42 to 2.55 2.89% 0.78 times
21 Fri Nov 2025 2.42 2.30 to 2.47 -2.02% 1.47 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top